A clinical trial among more than 300 patients has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy (PDR), a complication of diabetes that can severely damage eyesight.
10-Nov-2015 2:05 PM EST Add to Favorites
Joslin Chief Academic Officer Dr. C. Ronald Kahn Is Awarded The Harold Hamm International Prize for Biomedical Research in Diabetes
The Harold Hamm Diabetes Center at the University of Oklahoma awarded C. Ronald Kahn, M.D., Chief Academic Officer and Senior Investigator at Joslin Diabetes Center and the Mary K. Iacocca Professor of Medicine at Harvard Medical School, the Harold...
5-Nov-2015 2:05 PM EST Add to Favorites
Dr. Peter Amenta has been named President and CEO of Joslin Diabetes Center. Joslin Diabetes Center has 300 scientists working toward a cure for diabetes and its complications. Each year more than 100 clinical trials and human subject studies are...
16-Sep-2015 8:00 AM EDT Add to Favorites
A follow-up study has shown that these peripheral lesions, which are not detected by traditional eye imaging, correlate very closely with the loss of retinal blood flow called retinal “non-perfusion” caused by loss of small blood vessels or...
10-Sep-2015 10:05 AM EDT Add to Favorites
Researchers at Joslin Diabetes Center found that one strain of mice which were genetically prone to become obese became resistant to excess weight gain after their populations of gut microbiota were transformed simply by an sharing an environment...
3-Sep-2015 11:05 AM EDT Add to Favorites
Investigators at the Joslin Diabetes Center now have shown that eyes with diabetic retinal lesions predominantly in peripheral areas of the retina that are seen in UWF images but not in traditional retinal photographs show surprisingly higher risks...
27-Aug-2015 2:05 PM EDT Add to Favorites
Joslin Diabetes Center Receives Three Awards from the Boston Business Journal’s 2015 Healthcare Heroes
The Boston Business Journal (BBJ) has selected three recipients from Joslin Diabetes Center to receive the 2015 Healthcare Heroes Awards, which honors those who have worked tirelessly to improve the overall health and wellness of those living in...
12-Aug-2015 12:05 PM EDT Add to Favorites
Joslin scientists have advanced understanding of how the cellular repair process is impaired in type 1 diabetes, which can cause cell death and lead to complications.
4-Aug-2015 12:05 PM EDT Add to Favorites
Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies
6-Jan-2015 11:00 AM EST
Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT
13-Nov-2013 1:00 PM EST
The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT
Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT